Giménez Mestre, María JoséAguilar, LorenzoAlou, LuisSevillano, David2024-12-032024-12-032024Giménez, M. J., Aguilar, L., Alou, L., & Sevillano, D. (2024). Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model. Pharmaceutical Research, 41, 1595–1597. https://doi.org/10.1007/s11095-024-03729-80724-8741http://hdl.handle.net/11268/13280This article comments on a paper published by Igarashi et al. (Pharm Res. 2023;40(7):1789–97), which describes an animal model for determining the optimal pharmacokinetic/pharmacodynamic (PK/PD) value for cefditoren against Streptococcus pneumoniae, to be used as a target parameter in a subsequent population pharmacokinetic analysis.engStreptococcus pneumoniaeAntibacterianosjournal article10.1007/s11095-024-03729-8open accessBacteriaFarmacologíaGoal 3: Ensure healthy lives and promote well-being for all at all agesGoal 10: Reduce inequality within and among countries